Global Roundup: Singapore Researchers Create Atlas of Gastric Cancer - read this article along with other careers information, tips and advice on BioSpace
Amgen today announced financial results for the third quarter of 2021. Key results include: Total revenues increased 4% to $6.7 billion in comparison to the third quarter of 2020, driven by higher unit demand, partially offset by lower net selling prices. Product sales increased 4% globally, driven by double-digit volume growth across a number of our products, including Prolia ® EVENITY ® Repatha ® and MVASI ® . .
/PRNewswire/ Arthrosi Therapeutics, Inc., a clinical-stage biotech company announced results from its renal impairment studies and human AME study. The.
/PRNewswire/ Arthrosi Therapeutics, Inc., a clinical-stage biotech company announced results from its renal impairment studies and human AME study. The.